[Image source=AP Yonhap News]

[Image source=AP Yonhap News]

View original image


[Asia Economy Reporter Cho Hyun-ui] On the 12th (local time), Prayut Chan-o-cha, the Prime Minister of Thailand, decided to publicly receive the AstraZeneca COVID-19 vaccine from the multinational pharmaceutical company but suddenly postponed it. This is the first case in Asia where AstraZeneca vaccine administration has been temporarily suspended.


The Thai Ministry of Health postponed the scheduled public vaccination of Prime Minister Prayut and cabinet ministers on that day, according to CNBC and local media.


A Thai Ministry of Health official explained at a press conference, "This is due to some European countries such as Denmark, Norway, and Iceland temporarily suspending AstraZeneca vaccine administration because of blood clot formation."


Ten European countries reported side effects of blood clots in people who received certain batches of the AstraZeneca vaccine and decided to temporarily suspend vaccinations as a precautionary measure.


Thailand secured 61 million doses of the AstraZeneca vaccine produced locally by Siam Bioscience, a royal-owned company, and originally planned to start vaccinations from June.



A Thai Ministry of Health official stated, "AstraZeneca is an excellent vaccine, but due to the recent situation, we have decided to temporarily suspend vaccinations."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing